82.1 F
San Fernando
Thursday, Mar 28, 2024

Oxygen Business Sale Approved

The shareholders of CHAD Therapeutics Inc. have approved a proposed $5.25 million sale of the company’s oxygen conserving business to Inovo Inc. The transaction is expected to close Feb. 15. Inovo is a privately held manufacturer of oxygen regulators and conservers based in Naples, Fla. “We intend to focus our future efforts on the sleep disorder market,” Earl Yager, CHAD’s president and CEO, said. “We believe that our sleep products offer unique features that can improve the diagnosis and treatment of obstructive sleep apnea. We recently filed an application with the FDA for clearance to begin marketing the first of our sleep products.”

Featured Articles

Related Articles